JP6617245B2 - Animal feed ingredients and their uses - Google Patents
Animal feed ingredients and their uses Download PDFInfo
- Publication number
- JP6617245B2 JP6617245B2 JP2015076670A JP2015076670A JP6617245B2 JP 6617245 B2 JP6617245 B2 JP 6617245B2 JP 2015076670 A JP2015076670 A JP 2015076670A JP 2015076670 A JP2015076670 A JP 2015076670A JP 6617245 B2 JP6617245 B2 JP 6617245B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- feed
- lecithin
- rumen
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001465754 Metazoa Species 0.000 title description 38
- 239000004615 ingredient Substances 0.000 title description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 58
- 239000000787 lecithin Substances 0.000 claims description 56
- 229940067606 lecithin Drugs 0.000 claims description 56
- 235000010445 lecithin Nutrition 0.000 claims description 56
- 238000004519 manufacturing process Methods 0.000 claims description 34
- 150000003904 phospholipids Chemical class 0.000 claims description 29
- 241000282849 Ruminantia Species 0.000 claims description 26
- 150000004666 short chain fatty acids Chemical class 0.000 claims description 18
- 235000013325 dietary fiber Nutrition 0.000 claims description 17
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 17
- 235000021391 short chain fatty acids Nutrition 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 11
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 5
- 238000009395 breeding Methods 0.000 claims description 3
- 230000001488 breeding effect Effects 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 57
- 210000004767 rumen Anatomy 0.000 description 47
- 238000000855 fermentation Methods 0.000 description 38
- 230000004151 fermentation Effects 0.000 description 38
- 241000283690 Bos taurus Species 0.000 description 28
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 28
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 26
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 22
- 240000002791 Brassica napus Species 0.000 description 18
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 18
- 239000000463 material Substances 0.000 description 18
- 235000013336 milk Nutrition 0.000 description 16
- 239000008267 milk Substances 0.000 description 16
- 210000004080 milk Anatomy 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- 235000019260 propionic acid Nutrition 0.000 description 14
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 14
- 239000004310 lactic acid Substances 0.000 description 13
- 235000014655 lactic acid Nutrition 0.000 description 13
- 239000000835 fiber Substances 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 244000144972 livestock Species 0.000 description 10
- 239000002994 raw material Substances 0.000 description 10
- 239000012530 fluid Substances 0.000 description 9
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 8
- 208000010444 Acidosis Diseases 0.000 description 8
- 235000010469 Glycine max Nutrition 0.000 description 8
- 244000068988 Glycine max Species 0.000 description 8
- 230000007950 acidosis Effects 0.000 description 8
- 208000026545 acidosis disease Diseases 0.000 description 8
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 8
- 235000021243 milk fat Nutrition 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 229940083466 soybean lecithin Drugs 0.000 description 8
- 239000012085 test solution Substances 0.000 description 8
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 229940098773 bovine serum albumin Drugs 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 235000013365 dairy product Nutrition 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 210000005075 mammary gland Anatomy 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 206010016717 Fistula Diseases 0.000 description 5
- 235000019484 Rapeseed oil Nutrition 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 230000003890 fistula Effects 0.000 description 5
- 238000004817 gas chromatography Methods 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 4
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229940005605 valeric acid Drugs 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 102000014171 Milk Proteins Human genes 0.000 description 3
- 108010011756 Milk Proteins Proteins 0.000 description 3
- 108010073771 Soybean Proteins Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000003975 animal breeding Methods 0.000 description 3
- 230000004596 appetite loss Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 208000019017 loss of appetite Diseases 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000021239 milk protein Nutrition 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 235000019710 soybean protein Nutrition 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 2
- 229920002488 Hemicellulose Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000021312 gluten Nutrition 0.000 description 2
- 239000004463 hay Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000021049 nutrient content Nutrition 0.000 description 2
- -1 phosphate ester Chemical class 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- 208000012802 recumbency Diseases 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000004460 silage Substances 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 239000010902 straw Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 244000045195 Cicer arietinum Species 0.000 description 1
- 235000010523 Cicer arietinum Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 101710089042 Demethyl-4-deoxygadusol synthase Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 239000004258 Ethoxyquin Substances 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 244000043158 Lens esculenta Species 0.000 description 1
- 206010024652 Liver abscess Diseases 0.000 description 1
- 240000004296 Lolium perenne Species 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000019735 Meat-and-bone meal Nutrition 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 235000019779 Rapeseed Meal Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194049 Streptococcus equinus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000009430 Thespesia populnea Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- CWRILEGKIAOYKP-SSDOTTSWSA-M [(2r)-3-acetyloxy-2-hydroxypropyl] 2-aminoethyl phosphate Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCCN CWRILEGKIAOYKP-SSDOTTSWSA-M 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 229960001714 calcium phosphate Drugs 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- 229910000361 cobalt sulfate Inorganic materials 0.000 description 1
- 229940044175 cobalt sulfate Drugs 0.000 description 1
- KTVIXTQDYHMGHF-UHFFFAOYSA-L cobalt(2+) sulfate Chemical compound [Co+2].[O-]S([O-])(=O)=O KTVIXTQDYHMGHF-UHFFFAOYSA-L 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- 229960000355 copper sulfate Drugs 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000019285 ethoxyquin Nutrition 0.000 description 1
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
- 229940093500 ethoxyquin Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000008642 heat stress Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000020121 low-fat milk Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 238000009406 nutrient management Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000004456 rapeseed meal Substances 0.000 description 1
- 235000018770 reduced food intake Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000020083 shōchū Nutrition 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 1
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 125000005457 triglyceride group Chemical group 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Description
本発明は、特定のレシチンを含む動物用飼料原料とその用途に関し、より詳細には消化機能を改善する飼料原料とその用途に関する。 The present invention relates to animal feed materials containing specific lecithin and uses thereof, and more particularly to feed materials that improve digestive function and uses thereof.
家畜の消化管の機能を調節することは、消化機能を改善し、消化機能の低下による病気を予防し、その結果、畜産産物を効率的に生産するのに有効である。消化管での消化には、摂食物の消化管内の発酵が大きく影響する。そのため、発酵を制御する微生物製剤を家畜へ投与することがよく行われる。 Regulating the function of the digestive tract of livestock is effective in improving digestive function and preventing diseases caused by degradation of digestive function, and as a result, producing livestock products efficiently. Digestion in the digestive tract is greatly influenced by fermentation in the digestive tract of food intake. Therefore, it is often performed to administer microbial preparations for controlling fermentation to livestock.
ウシ等の反芻動物は、通常の動物で利用できないような繊維質をエネルギー源として利用するために、ルーメン(第一胃)という反芻胃を発達させている。ルーメン内は、摂取した飼料、唾液、発酵産物等によって恒常性が保たれ、微生物が棲息するのに適した環境となっている。 Ruminants such as cows have developed ruminants called rumen (ruminals) in order to use fiber as an energy source that cannot be used in normal animals. Inside the lumen, the homeostasis is maintained by the ingested feed, saliva, fermentation products, etc., and the environment is suitable for microorganisms to live.
ルーメン発酵の経路を図1に示す。飼料には、セルロース、ヘミセルロース、デンプン等の炭水化物が大量に含まれる。炭水化物は、ルーメン内の微生物の酵素によって、酢酸、酪酸、プロピオン酸等の短鎖脂肪酸(VFAや揮発性脂肪酸ともいう)、乳酸、メタン、二酸化炭素、水素等に変換される。変換された短鎖脂肪酸の大部分は、ルーメン壁から吸収され、動物の主要なエネルギー源となる。この場合、特に酢酸、プロピオン酸の生成を促すことが好ましい。 The route of rumen fermentation is shown in FIG. The feed contains a large amount of carbohydrates such as cellulose, hemicellulose, and starch. Carbohydrates are converted into short-chain fatty acids (also referred to as VFA or volatile fatty acids) such as acetic acid, butyric acid, and propionic acid, lactic acid, methane, carbon dioxide, hydrogen, and the like by microbial enzymes in the rumen. Most of the converted short chain fatty acids are absorbed from the lumen wall and become the primary source of energy for animals. In this case, it is particularly preferable to promote the production of acetic acid and propionic acid.
ルーメン発酵経路の途中で生成する乳酸がプロピオン酸へ変換されないまま、ルーメン内に蓄積すると、反芻動物の生育に影響を及ぼす。非特許文献1によれば、ルーメンpHが5.8以下の状態を亜急性ルーメンアシドーシスという。亜急性ルーメンアシドーシスが続くと、家畜は、摂餌量の低下、下痢、ルーメン粘液の損傷、蹄葉炎、肝膿瘍等の疾病を発する。ルーメンアシドーシスは、ルーメン内でLactobacillus、Streptococcus bovis等の乳酸産生菌が増殖して、乳酸がルーメン内に蓄積し、ルーメン液のpH(以下、「ルーメンpH」という)が5以下となる状態をいう。ルーメンアシドーシスになると、家畜は、食欲喪失、乳量激減、横臥、起立不能等の臨床症状を示す。したがって、反芻動物のルーメン内の乳酸の蓄積を抑え、乳酸からプロピオン酸の変換を促進する手法が望まれる。一方、ピルビン酸からアセチルCoAへの変換を促す手法も、乳酸の蓄積量を抑制するために有効である。 The accumulation of lactic acid produced in the course of the rumen fermentation pathway in the rumen without being converted to propionic acid affects the growth of ruminants. According to Non-Patent Document 1, a state where the lumen pH is 5.8 or less is referred to as subacute rumen acidosis. If subacute rumen acidosis continues, livestock will develop diseases such as reduced food intake, diarrhea, rumen mucus damage, lobe inflammation, and liver abscesses. Rumen acidosis refers to a state in which lactic acid-producing bacteria such as Lactobacillus and Streptococcus bovis grow in the lumen and the lactic acid accumulates in the lumen, so that the pH of the rumen solution (hereinafter referred to as “lumen pH”) is 5 or less. . When it comes to rumen acidosis, livestock show clinical symptoms such as loss of appetite, severe milk loss, recumbency and inability to stand. Therefore, a technique is desired that suppresses the accumulation of lactic acid in rumen of ruminants and promotes the conversion of lactic acid to propionic acid. On the other hand, a method for promoting conversion of pyruvic acid to acetyl CoA is also effective for suppressing the amount of accumulated lactic acid.
動物の飼育においては、限られた穀物資源をより有効に利用することも重要な課題である。例えば、反芻動物用飼料が反芻胃で発酵して得られる短鎖脂肪酸が、乳腺で乳脂肪、乳糖及び乳タンパク質を合成するための原料となる。 In animal breeding, more effective use of limited grain resources is also an important issue. For example, short-chain fatty acids obtained by fermenting ruminant feed in the rumen serve as raw materials for synthesizing milk fat, lactose and milk protein in the mammary gland.
乳成分の合成量は、乳腺に蓄えられるグルコース、アミノ酸、酢酸、酪酸、遊離脂肪酸、グリセリン、無機物類等の乳成分原料によって規定される。乳成分原料の生成量は、給与飼料中の炭水化物、タンパク質及び脂質の化学的特性(消化性や代謝・内分泌特性)とその配合比率によって大きく変動する。 The synthesis amount of milk components is defined by milk component materials such as glucose, amino acids, acetic acid, butyric acid, free fatty acids, glycerin and inorganic substances stored in the mammary gland. The amount of dairy ingredients produced varies greatly depending on the chemical characteristics (digestibility, metabolism and endocrine characteristics) of the carbohydrates, proteins and lipids in the feed and their blending ratio.
非特許文献2によれば、乳牛に酢酸を給与することで、乳量の増加、乳脂肪濃度及び乳糖濃度が上昇し、またプロピオン酸を給与することで乳タンパク質濃度が上昇することが報告されている。 According to Non-Patent Document 2, it is reported that feeding acetic acid to dairy cows increases milk yield, milk fat concentration and lactose concentration, and feeding propionic acid raises milk protein concentration. ing.
牛乳の乳脂率は、平均3.9%である。乳脂肪の主成分は、97〜98%を占めるトリグリセリド(TG)である。TGを構成するC4〜C16脂肪酸は、ルーメン内で生産された酢酸及び酪酸を用いて乳腺で合成される。C16〜C18脂肪酸は、飼料由来の脂肪や体脂肪から乳脂肪に取り込まれる。よって、乳脂率は、飼養管理によっても変動する。 The milk fat percentage of milk is 3.9% on average. The main component of milk fat is triglyceride (TG) occupying 97-98%. C4-C16 fatty acids constituting TG are synthesized in the mammary gland using acetic acid and butyric acid produced in the lumen. C16-C18 fatty acids are taken into milk fat from fat and body fat derived from feed. Therefore, the milk fat percentage varies depending on the feeding management.
非特許文献3(p91〜92)によれば、低脂肪乳の現象としては、濃厚飼料の給比率の上昇や粗飼料の給比率の減少によってルーメン内の発酵パターンが変化して、酢酸や酪酸の供給量が不足すること、同様の原因によりプロピオン酸の生産量やグルコース供給量が増加し、内分泌制御に起因する乳腺への脂肪供給不足が生じること、不飽和度の高い植物性脂肪の過給によりルーメン内の微生物叢が影響を受けること、乳腺におけるトランス型多価不飽和脂肪酸による乳脂肪酸合成が阻害されること等が指摘されている。したがって、低乳脂肪の発生を防止するには、ルーメン内発酵を適切に維持し、ルーメン内でのVFA(特に酢酸及び酪酸)の生成を促進することが重要である。そして、ルーメン内を酢酸が優勢となる発酵状態に維持し、乳腺への酢酸供給量を増加させるためには、飼料の粗飼料配合量の適正化に加えて、繊維の消化性を改善することが重要である。よって、乳の生産量及び乳成分量を高めるために、飼料を特定の短鎖脂肪酸へ効率的に変換できることが望ましい。 According to Non-Patent Document 3 (p. 91 to 92), as a phenomenon of low fat milk, the fermentation pattern in the rumen changes due to the increase in the feed ratio of the concentrated feed or the decrease in the feed ratio of the rough feed, and acetic acid and butyric acid. Insufficient supply, increased production of propionic acid and glucose supply due to similar causes, resulting in insufficient supply of fat to the mammary gland due to endocrine control, supercharging of highly unsaturated vegetable fat It has been pointed out that the microflora in the rumen is affected by this, and that milk fatty acid synthesis by trans polyunsaturated fatty acids in the mammary gland is inhibited. Therefore, in order to prevent the generation of low milk fat, it is important to properly maintain the fermentation in the rumen and promote the production of VFA (particularly acetic acid and butyric acid) in the rumen. In order to maintain the rumen in a fermented state where acetic acid is dominant and increase the amount of acetic acid supplied to the mammary gland, in addition to optimizing the amount of feed roughage, the digestibility of the fiber can be improved. is important. Therefore, it is desirable to be able to efficiently convert feed to specific short chain fatty acids in order to increase milk production and milk component amounts.
反芻動物は、夏場の暑熱ストレスにより、飼料の摂取量が低下し、生体内のエネルギーが不足して乳量や乳成分量が低下することが知られている。泌乳初期には、摂食エネルギーよりも乳として排出されるエネルギーの方が多くなる。体内のエネルギーバランスがマイナスとなることと、代謝障害や繁殖障害の発生が多くなることが知られている(非特許文献3 p57−64)。 Ruminants are known to have low feed intake due to heat stress in summer, resulting in insufficient in vivo energy and reduced milk yield and milk component content. In early lactation, more energy is released as milk than energy consumed. It is known that the energy balance in the body becomes negative, and the occurrence of metabolic disorders and reproductive disorders increases (Non-patent Document 3, p57-64).
高泌乳牛やその他の家畜のエネルギー源として、特に暑熱時のエネルギー補給用に、脂肪酸カルシウムを配合した飼料を給与する方法が知られている。(非特許文献3 p91−92)。脂肪酸カルシウムは、ルーメン内では消化されず、第四胃以降で消化吸収されるため、エネルギーを効率良く補給できるとされる。 As an energy source for high-lactation cows and other livestock, there is known a method of feeding a diet containing fatty acid calcium, particularly for energy supplementation during hot weather. (Nonpatent literature 3 p91-92). Fatty acid calcium is not digested in the lumen, but is digested and absorbed in the fourth and subsequent stomachs, so that energy can be efficiently replenished.
これらの従来方法は、不足しがちとなった生体内のエネルギーの補完を目的とするものであり、家畜の消化管内での発酵を促進するものではなかった。 These conventional methods are intended to supplement in vivo energy that tends to be insufficient, and do not promote fermentation in the digestive tract of livestock.
そこで、本発明の課題は、動物の消化管内の発酵を促進することにより、消化を改善し、病気を予防し、飼料の利用効率を高め、そして少量の飼料で畜産産物を効率的に生産する技術を提供することにある。 Therefore, the object of the present invention is to promote fermentation in the digestive tract of animals, thereby improving digestion, preventing diseases, increasing feed utilization efficiency, and efficiently producing livestock products with a small amount of feed. To provide technology.
本発明者らは、前記課題を鋭意検討した結果、特定のレシチンを含む飼料原料を動物に給与することにより、前記課題を解決できることを見出した。すなわち、本発明は、アセトン可溶物含有量が10質量%以下であり、全リン脂質に対するホスファチジルコリン含量が25〜50質量%であるレシチンを含む動物用飼料原料を提供する。 As a result of intensive studies on the above problems, the present inventors have found that the above problems can be solved by feeding a feed material containing a specific lecithin to animals. That is, this invention provides the animal feed raw material containing lecithin whose acetone soluble substance content is 10 mass% or less and whose phosphatidylcholine content with respect to all the phospholipids is 25-50 mass%.
上記動物用飼料原料は、例えば消化管での短鎖脂肪酸産生を向上させるために使用される。 The animal feed material is used, for example, to improve the production of short chain fatty acids in the digestive tract.
本発明は、また、上記動物用飼料原料を、リン脂質の質量基準で0.1〜5質量%含む飼料を提供する。 The present invention also provides a feed comprising 0.1 to 5% by mass of the animal feed material described above on a phospholipid mass basis.
上記動物用飼料は、10質量%以上の粗飼料を含むことが好ましい。本明細書において、粗飼料という用語は、粗繊維含量が高く、可消化養分が少ない成分を意味する。 The animal feed preferably contains 10% by mass or more of rough feed. In the present specification, the term roughage means a component having a high crude fiber content and a low digestible nutrient content.
上記動物用飼料は、特に反芻動物用である。 The animal feed is especially for ruminants.
本発明は、また、上記動物用飼料原料を、リン脂質の質量基準で8〜400g/日、動物に給与することを含む、動物の飼育方法を提供する。 The present invention also provides an animal breeding method comprising feeding the animal feed material to the animal at a rate of 8 to 400 g / day on a phospholipid mass basis.
本発明は、また、アセトン可溶物含有量が10質量%以下であり、全リン脂質に対するホスファチジルコリン含量が25〜50質量%であるレシチンを含む、消化管での短鎖脂肪酸産生向上剤を提供する。 The present invention also provides a short-chain fatty acid production improver in the digestive tract, comprising lecithin having an acetone-soluble matter content of 10% by mass or less and a phosphatidylcholine content of 25 to 50% by mass relative to the total phospholipids. To do.
本発明は、また、上記短鎖脂肪酸産生向上剤を動物に給与することを含む、動物の消化管での短鎖脂肪酸の産生を向上させる方法を提供する。 The present invention also provides a method for improving the production of short-chain fatty acids in the digestive tract of animals, comprising feeding the animal with the above-mentioned agent for improving production of short-chain fatty acids.
特定のレシチンを含む本発明の動物用飼料原料を飼料に添加すると、それを給餌された動物は、消化管の発酵が促進される。消化管の発酵促進は、飼料中に含まれる繊維質(セルロースやヘミセルロース)のような発酵し難い炭水化物を微生物が代謝しやすくする。 When the animal feed material of the present invention containing specific lecithin is added to the feed, fermentation of the digestive tract is promoted in the animals fed with the feed material. The promotion of fermentation in the digestive tract makes it easier for microorganisms to metabolize unfermentable carbohydrates such as fibers (cellulose and hemicellulose) contained in feed.
飼料が粗飼料(その主要成分は繊維質である)を例えば10質量%以上含む場合、本発明の動物用飼料原料が、消化管での繊維質の発酵を顕著に促進し、繊維質から短鎖脂肪酸(VFA)への変換と導く。具体的には、VFAの総産生量(酢酸、プロピオン酸、酪酸、イソ酪酸、吉草酸、イソ吉草酸の全てを合わせたもの)が増大する。VFAの中でも、動物の主要なエネルギー源となり得る有益な酢酸、プロピオン酸及び酪酸の産生が特に促進される。 When the feed contains roughage (the main component of which is fiber), for example, 10% by mass or more, the animal feed material of the present invention significantly promotes the fermentation of the fiber in the digestive tract, and the short chain from the fiber. Lead to conversion to fatty acid (VFA). Specifically, the total production amount of VFA (a combination of all of acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, and isovaleric acid) increases. Among VFAs, the production of beneficial acetic acid, propionic acid and butyric acid, which can be a major energy source for animals, is particularly accelerated.
本発明の動物用飼料原料は、VFAを定量的にも定性的にも優位に産生する結果として、飼料の利用効率を改善し、すなわち少量の飼料で畜産産物を効率的に生産することを可能とする。乳牛の場合には、乳量の増加、乳脂肪濃度、乳糖濃度及び乳タンパク濃度の上昇も可能である。肉牛の場合には、体重の増加と肉質の改善が可能である。 The animal feed material of the present invention can improve the utilization efficiency of feed as a result of producing VFA in a quantitative and qualitative manner, that is, it can efficiently produce livestock products with a small amount of feed. And In the case of dairy cows, it is also possible to increase milk yield, increase milk fat concentration, lactose concentration and milk protein concentration. In the case of beef cattle, it is possible to gain weight and improve meat quality.
反芻動物のルーメン発酵経路の途中で生成する乳酸がルーメン内に蓄積すると、ルーメン液のpHが下がり、ルーメンアシドーシスになる。その結果、反芻動物は、食欲喪失、乳量激減、横臥、起立不能等の病気を招来しやすい。本発明の飼料原料をリン脂質の質量基準で8〜400g/日、動物に給与することを含む本発明の動物の飼育方法によれば、上記乳酸はプロピオン酸に変換されやすくなる。また、ピルビン酸からアセチルCoAへの変換が促進することで乳酸の産生が抑制され酢酸産生量が増加する。したがって、反芻動物のルーメンアシドーシスやそれによる食欲喪失、乳量激減、横臥、起立不能等の病気を予防することができる。 When lactic acid produced in the rumen fermentation pathway of ruminants accumulates in the rumen, the pH of the rumen fluid decreases and rumen acidosis occurs. As a result, ruminants are prone to diseases such as loss of appetite, drastic reduction of milk yield, lying down, and inability to stand. According to the animal breeding method of the present invention including feeding the feed raw material of the present invention to the animal at 8 to 400 g / day based on the mass of phospholipid, the lactic acid is easily converted to propionic acid. In addition, the promotion of conversion of pyruvic acid to acetyl CoA suppresses the production of lactic acid and increases the amount of acetic acid produced. Therefore, ruminant acidosis in ruminants and the resulting diseases such as loss of appetite, drastic reduction of milk production, recumbency and inability to stand up can be prevented.
ルーメン内でのVFAの増産、及びルーメンアシドーシスとそれに基づく病気の予防という効果は、飼料原料の形態のほかに、アセトン可溶物含有量が10質量%以下であり、全リン脂質に対するホスファチジルコリン含量が25〜50質量%であるレシチンを含む、消化管での短鎖脂肪酸産生向上剤という形態で動物に単独投与することによっても得られる。 The effects of increasing production of VFA in rumen, and prevention of rumen acidosis and diseases based thereon, in addition to the form of feed material, the content of soluble acetone is 10% by mass or less, and the content of phosphatidylcholine with respect to total phospholipids It can also be obtained by single administration to an animal in the form of a short-chain fatty acid production improver in the digestive tract, which contains 25 to 50% by mass of lecithin.
本発明の動物用飼料原料は、アセトン可溶物含有量が10質量%以下であり、全リン脂質に対するホスファチジルコリン含量が25〜50質量%であるレシチンを含む。このレシチンは、アセトン可溶物含有量が上記範囲である限り、その由来を問わない。例えば、レシチンの原料種子には、大豆、菜種、ひまわり、綿実、とうもろこし、落花生、パーム、ゴマ、米、紅花、エゴマ、アマニ等が挙げられる。好ましくは大豆及び菜種である。 The animal feed material of the present invention contains lecithin having an acetone-soluble matter content of 10% by mass or less and a phosphatidylcholine content of 25 to 50% by mass relative to the total phospholipids. The lecithin is not limited in its origin as long as the content of soluble acetone is within the above range. For example, raw material seeds for lecithin include soybean, rapeseed, sunflower, cottonseed, corn, peanut, palm, sesame, rice, safflower, egoma, flaxseed and the like. Soybeans and rapeseed are preferable.
リン脂質は、分子構造中にリン酸エステルを持った脂質である。リン脂質の具体例には、ホスファチジルコリン(狭義のレシチン)、ホスファチジルエタノールアミン、リゾホスファチジルコリン、リゾホファチジルエタノールアミン、ホスファチジルイノシトール、ホスファチジルセリン、ホスファチジン酸、スフィンゴミエリン等がある。本明細書において、「レシチン」という用語は、少なくとも一種の上記リン脂質を含み、さらに糖脂質、オリゴ糖のような不純物を含み得る混合物を意味する。 A phospholipid is a lipid having a phosphate ester in its molecular structure. Specific examples of phospholipids include phosphatidylcholine (lecithin in a narrow sense), phosphatidylethanolamine, lysophosphatidylcholine, lysophosphatidylethanolamine, phosphatidylinositol, phosphatidylserine, phosphatidic acid, sphingomyelin and the like. In the present specification, the term “lecithin” means a mixture containing at least one kind of the phospholipid and further containing impurities such as glycolipid and oligosaccharide.
本発明に使用可能のレシチンのアセトン可溶物含有量は、10質量%以下であり、好ましく4質量%以下であり、さらに好ましくは3質量%以下である。このようなレシチンは、例えば、植物油の製造工程中の脱ガム工程で分離されるガム質を、通常、水分1%以下に乾燥することによりクルードレシチンを得て、次に、このクルードレシチンを溶剤分別にかけて、脂質及びその他の微量成分を除去することにより得られる。こうして得られるレシチンを、以下、脱油レシチンということがある。脱油レシチンの組成は、油糧種子によって変動するが、リン脂質を通常、50〜80質量%を含み、好ましくは55〜75%質量%含む。 The acetone-soluble matter content of lecithin that can be used in the present invention is 10% by mass or less, preferably 4% by mass or less, and more preferably 3% by mass or less. Such lecithin is obtained, for example, by obtaining crude lecithin by drying the gum that is separated in the degumming step in the vegetable oil production process to a moisture content of 1% or less, and then using the crude lecithin as a solvent. It is obtained by removing the lipid and other trace components through fractionation. The lecithin thus obtained may be hereinafter referred to as deoiled lecithin. The composition of deoiled lecithin varies depending on the oil seed, but usually contains 50 to 80% by mass, preferably 55 to 75% by mass of phospholipid.
本発明の動物用飼料原料には、上記レシチン以外に、本発明の作用効果を阻害しない限り、保存安定性や酸化安定性向上を目的としたエトキシキン、BHT、BHA、TBHQ、トコフェロール、アスコルビン酸、アスコルビン酸パルミテート等の助剤を添加可能である。 In addition to the above lecithin, the animal feed material of the present invention includes ethoxyquin, BHT, BHA, TBHQ, tocopherol, ascorbic acid for the purpose of improving storage stability and oxidation stability, as long as the effects of the present invention are not inhibited. An auxiliary agent such as ascorbyl palmitate can be added.
本発明は、また、上記動物用飼料原料を含む動物用飼料を提供する。上記レシチン以外の飼料原料として、生草、サイレージ、乾草、わら類;米、玄米、ライ麦、小麦、大麦、トウモロコシ、マイロ、大豆等の穀類;大豆粕、脱皮大豆粕、大豆蛋白濃縮物、分離大豆蛋白、大豆蛋白分離副産物、菜種粕、綿実粕、ルピナス種粕、コーングルテンミール、コーングルテンフィード、アルファルファ粉、ポテトプロテイン、ヒヨコマメ、エンドウマメ、インゲンマメ、レンズマメ、ブラックビーン、等の植物性蛋白源;肉骨粉、血粉、フェザーミール、ポークミール、チキンミール、脱脂粉乳等の動物性蛋白源;植物性油脂、動物性油脂、粉末精製牛脂、肝油等の油脂類;バイオエタノール蒸留粕(DDGS)、ビール粕、焼酎粕、酒粕、ワイン粕、ウイスキー粕、醤油粕等の発酵副産物類;おから、茶抽出粕、野菜・果物抽出粕、コーヒー粕等の食品工業副産物類;リジン、メチオニン、スレオニン、トリプトファン、バリン、イソロイシン等のアミノ酸類;ビタミンB1、ビタミンB2、ビタミンB6、ビタミンB12、パントテン酸カルシウム、ニコチン酸アミド、葉酸、ビタミンC、ビオチン、コリン等のビタミン類又はビタミン用作用物質;亜鉛、カルシウム、セレン、鉄、リン等のミネラル類;硫酸マグネシウム、硫酸鉄、硫酸銅、硫酸亜鉛、ヨウ化カリウム、硫酸コバルト、炭酸カルシウム、リン酸三カルシウム、塩化ナトリウム、リン酸カルシウム、塩化コリン等の無機塩類;色素が挙げられる。 The present invention also provides an animal feed comprising the animal feed material. As raw materials for feed other than lecithin, raw grass, silage, hay, straw; rice, brown rice, rye, wheat, barley, corn, milo, soybean, etc .; soybean meal, molted soybean meal, soybean protein concentrate, separation Vegetable protein such as soybean protein, soybean protein separation by-product, rapeseed meal, cottonseed meal, lupine meal, corn gluten meal, corn gluten feed, alfalfa powder, potato protein, chickpea, pea, kidney bean, lentil, black bean, etc. Sources: Animal protein sources such as meat-and-bone meal, blood meal, feather meal, pork meal, chicken meal, and skim milk powder; fats and oils such as vegetable oils, animal oils, powdered beef tallow, liver oil; bioethanol distillers (DDGS) Fermentation by-products such as beer lees, shochu lees, sake lees, wine lees, whiskey lees, soy sauce lees; okara, tea extract lees, fields・ Food industry by-products such as fruit extract koji, coffee koji; amino acids such as lysine, methionine, threonine, tryptophan, valine, isoleucine; vitamin B1, vitamin B2, vitamin B6, vitamin B12, calcium pantothenate, nicotinamide, Vitamins such as folic acid, vitamin C, biotin, and choline or active substances for vitamins; minerals such as zinc, calcium, selenium, iron, and phosphorus; magnesium sulfate, iron sulfate, copper sulfate, zinc sulfate, potassium iodide, cobalt sulfate Inorganic salts such as calcium carbonate, tricalcium phosphate, sodium chloride, calcium phosphate, choline chloride; and pigments.
乳牛、肉牛の飼料分野では、上記動物用飼料原料が、可消化養分や粗繊維の含量によって、粗飼料と濃厚飼料とに大別される。粗飼料は、粗繊維含量が高く、可消化養分が少ない成分である。具体的には、生草、サイレージ、乾草、わら類、等が含まれる。 In the field of dairy cattle and beef cattle feed, the animal feed materials are roughly classified into rough feed and concentrated feed according to digestible nutrients and the content of crude fiber. The roughage is a component having a high content of coarse fibers and a low digestible nutrient content. Specifically, raw grass, silage, hay, straw, and the like are included.
濃厚飼料は、可消化養分が多く、粗繊維含量が低い成分である。具体的には、穀類、そうこう類、植物性油かす類、発酵副産物類等が含まれる。 Concentrated feed is a component with high digestible nutrients and low crude fiber content. Specifically, cereals, algae, vegetable oil cakes, fermentation by-products and the like are included.
反芻動物のルーメン内発酵を安定的に維持する基本的な栄養管理指標として、従来、粗飼料と濃厚飼料の比率(粗濃比)が採用されている。反芻動物へ与える飼料の粗濃比は、粗飼料給与比率で通常、10〜90質量%である。 As a basic nutrient management index for stably maintaining rumen fermentation in ruminants, the ratio of roughage to concentrated feed (roughness ratio) has been conventionally employed. The rough concentration ratio of feed given to ruminants is usually 10 to 90% by weight in terms of feed ratio.
VFA、特に酢酸は、一般的に、粗飼料を発酵した際に生産されるが、発酵性が悪いと言われている。本発明の飼料原料は、後述の実施例1〜4に示すように、粗飼料の発酵を促進することでVFAの産生を促している。したがって、本発明の飼料原料を給与することは、乳牛の場合には乳量の増加、乳成分量の増加が期待でき、肉牛の場合には増体、肉質の改善効果が期待できる。 VFA, particularly acetic acid, is generally produced when fermenting roughage, but is said to have poor fermentability. As shown in Examples 1 to 4 described later, the feed raw material of the present invention promotes the production of VFA by promoting fermentation of the roughage. Therefore, feeding the feed raw material of the present invention can be expected to increase the milk amount and the amount of milk components in the case of dairy cows, and to increase the body weight and improve the meat quality in the case of beef cattle.
本発明の動物用飼料原料を含む動物用飼料において、粗飼料の下限の割合は、通常、10質量%であり、好ましくは15質量%であり、さらに好ましくは30質量%である。一方、粗飼料の上限の割合は、通常、90質量%であり、好ましくは80質量%であり、さらに好ましくは60質量%である。 In the animal feed containing the animal feed raw material of the present invention, the lower limit ratio of the rough feed is usually 10% by mass, preferably 15% by mass, and more preferably 30% by mass. On the other hand, the upper limit of the roughage is usually 90% by mass, preferably 80% by mass, and more preferably 60% by mass.
本発明の動物用飼料は、前記動物用飼料原料を、リン脂質質量で通常、0.1〜5質量%、好ましくは0.1〜4質量%、より好ましくは0.2〜3質量%含む。 The animal feed of the present invention contains the animal feed material in an amount of usually 0.1 to 5% by mass, preferably 0.1 to 4% by mass, more preferably 0.2 to 3% by mass in terms of phospholipid mass. .
本発明の動物用飼料には、飼料の品質の低下防止、栄養成分の有効利用の促進等のために、栄養源以外の助剤を、本発明の効果を阻害しない範囲で使用してもよい。そのような例には、抗酸化剤、防カビ剤、粘結剤、乳化剤、pH調整剤、抗菌剤、呈味料、着香料、酵素、生菌剤、有機酸等が挙げられる In the animal feed of the present invention, auxiliary agents other than nutrient sources may be used within a range that does not impair the effects of the present invention in order to prevent deterioration of the feed quality, promote effective use of nutrient components, and the like. . Examples thereof include antioxidants, fungicides, binders, emulsifiers, pH adjusters, antibacterial agents, flavoring agents, flavoring agents, enzymes, viable agents, organic acids and the like.
本発明の動物用飼料原料の適用対象は、ウシ、ヤギ、ヒツジ等の反芻動物、ブタ、ウマ、ウサギ、ニワトリ、アヒル、七面鳥、ガチョウ、アイガモ、キジ、魚類等の家畜動物や犬、猫等の愛玩動物である。好ましくは、ウシ、ヤギ、ヒツジ等の反芻動物であり、より好ましくはウシである。 Applicable objects of the animal feed material of the present invention are ruminants such as cattle, goats and sheep, domestic animals such as pigs, horses, rabbits, chickens, ducks, turkeys, geese, aigamo, pheasants, fish, dogs, cats, etc. Is a pet animal. Preferred are ruminants such as cows, goats and sheep, and more preferred are cows.
アセトン可溶物含有量が10質量%以下であり、全リン脂質中のホスファチジルコリン含量が25〜50質量%であるレシチンは、上記したとおり、消化管での短鎖脂肪酸産生を向上させる。本発明は、前記レシチンを、飼料原料用途以外に、消化管での短鎖脂肪酸産生向上剤としての用途もまた提供する。本発明は、また、上記短鎖脂肪酸産生向上剤を動物に給与することを含む、動物の消化管での短鎖脂肪酸の産生を向上させる方法もまた、提供する。 Lecithin having an acetone-soluble substance content of 10% by mass or less and a phosphatidylcholine content in the total phospholipid of 25 to 50% by mass improves short-chain fatty acid production in the digestive tract as described above. The present invention also provides a use of the lecithin as a short-chain fatty acid production improver in the digestive tract, in addition to the feed raw material. The present invention also provides a method for improving the production of short-chain fatty acids in the digestive tract of animals, comprising feeding the animal with the above-mentioned agent for improving production of short-chain fatty acids.
以下に、実施例及び比較例を示して、本発明をより詳細に説明する。しかし、本発明は、以下の実施例に限定されるものではない。
〔実施例1〜4、比較例1〜3〕脱油レシチンのin vitro試験
in vitroのウシルーメン液を用いた発酵試験において、脱油レシチンが添加されたときの、短鎖脂肪酸の生成に及ぼす影響を調べた。比較のため、大豆又は菜種由来の脂質(大豆油又は菜種油)が添加されたときの発酵試験も行なった。
Hereinafter, the present invention will be described in more detail with reference to Examples and Comparative Examples. However, the present invention is not limited to the following examples.
[Examples 1 to 4, Comparative Examples 1 to 3] In vitro test of deoiled lecithin Effect of adding deoiled lecithin on the production of short chain fatty acids in in vitro fermentation test using bovine rumen fluid I investigated. For comparison, a fermentation test was also performed when lipid derived from soybean or rapeseed (soybean oil or rapeseed oil) was added.
(1)飼料Aの作製
粗飼料としてイタリアンライグラス(乾草)と濃厚飼料として市販濃厚飼料(製品名:そよ風の薫り、日本配合飼料株式会社製)とを質量基準で1:1にて混合することにより飼料Aを得た。以下、粗飼料と濃厚飼料との比率(質量基準)を、粗濃比ということがある。市販濃厚飼料の表示を表1に示す。
(1) Preparation of feed A By mixing Italian ryegrass (hay) as a rough feed and a commercially available concentrated feed (product name: soft breeze, made by Nippon Compound Feed Co., Ltd.) as a thick feed at a mass ratio of 1: 1. Feed A was obtained. Hereinafter, the ratio (mass basis) between the roughage and the concentrated feed may be referred to as a crude concentration ratio. Table 1 shows the display of commercially available concentrated feed.
(2)脱油レシチンの準備
脱油レシチンとして菜種由来のものと大豆由来のものを、以下の手順で用意した。
(2)−1脱油菜種レシチンの調製
菜種油製造時の脱ガム工程で副生したガム質を、減圧乾燥することにより、クルード菜種レシチンを得た。クルード菜種レシチンは、アセトン可溶物35〜40質量%を含む粘稠なペースト状であった。このクルード菜種レシチンを5倍量のアセトンに溶解し、静置分離にて下層を回収し、再び5倍量のアセトンに溶解した。この操作を5回繰り返した。得られた下層部を減圧乾燥することにより、アセトン可溶物が1.0質量%になるまで脱油された菜種レシチンを得た。また、この菜種由来の脱油レシチンは、1.0質量%の水分を有し、粉末状であった。脱油菜種レシチンの組成を、表2に示す。
(2) Preparation of deoiled lecithin A rapeseed-derived one and a soybean-derived one were prepared as the deoiled lecithin by the following procedure.
(2) -1 Preparation of Deoiled Rapeseed Lecithin Crude rapeseed lecithin was obtained by drying under reduced pressure the gum that was by-produced in the degumming step during the production of rapeseed oil. Crude rapeseed lecithin was a viscous paste containing 35-40% by mass of acetone-soluble matter. This crude rapeseed lecithin was dissolved in 5 times amount of acetone, the lower layer was recovered by stationary separation, and dissolved again in 5 times amount of acetone. This operation was repeated 5 times. The resulting lower layer was dried under reduced pressure to obtain rapeseed lecithin deoiled until the acetone-soluble matter became 1.0% by mass. The rapeseed-derived deoiled lecithin had a water content of 1.0% by mass and was in the form of a powder. The composition of deoiled rapeseed lecithin is shown in Table 2.
(2)−2脱油大豆レシチンの準備
大豆由来の脱油レシチンには、市販の脱油大豆レシチン(製品名:レシチンPW、株式会社J−オイルミルズ製)を用意した。この脱油大豆レシチンの水分は、2.0質量%、そしてアセトン可溶物は2.8質量%であった。脱油大豆レシチンの組成を、表2に示す。
(2) -2 Preparation of Deoiled Soybean Lecithin Commercially deoiled soybean lecithin (product name: lecithin PW, manufactured by J-Oil Mills Co., Ltd.) was prepared as the deoiled lecithin derived from soybean. The water content of the deoiled soybean lecithin was 2.0% by mass, and the acetone-soluble matter was 2.8% by mass. The composition of deoiled soy lecithin is shown in Table 2.
(3)ルーメン液採取
ルーメンフィステルを装着したF1ウシ(月齢40ヶ月)をルーメン液発酵試験に用いた。このウシを、コンクリート敷の牛房へ個体ごとに収容した。ウシに飼料Aを、1日当たり8kg(濃厚飼料4kg/日)、3週間、給与した。なお、試験3週間前及び試験中は、ウシに抗菌剤、その他薬剤を投与しなかった。
(3) Rumen fluid collection F1 cattle (40 months old) equipped with a rumen fistula was used for the rumen fluid fermentation test. The cows were housed individually in a concrete bed. Cattle were fed 8 kg of feed A per day (4 kg of concentrated feed / day) for 3 weeks. In addition, antibacterial agents and other drugs were not administered to cattle 3 weeks before and during the test.
(4)発酵試験
飼料Aの3週間給与の翌朝(給餌前)に、ウシからルーメン液を約500mL採取した。採取したルーメン液500mLを4重ガーゼで濾過した。この濾液とMcDougall’s Bufferとを5:4の割合で混合することにより、ルーメン濾液を希釈した。得られたルーメン希釈液9mLを15mL容バイアル瓶に分注した。
(4) Fermentation test On the morning of feeding A for 3 weeks (before feeding), about 500 mL of rumen fluid was collected from the cow. 500 mL of the collected rumen solution was filtered with quadruple gauze. The rumen filtrate was diluted by mixing this filtrate with McDougal's Buffer in a ratio of 5: 4. 9 mL of the obtained lumen diluted solution was dispensed into a 15 mL vial.
McDougall’s Bufferに1質量%のウシ血清アルブミン(BSA)及び菜種由来又は大豆由来の脱油レシチンを1質量%又は3質量%を加えた液を、超音波発生器にかけて、BSA乳化液を作製した。 A solution obtained by adding 1% by mass bovine serum albumin (BSA) and 1% by mass or 3% by mass of rapeseed-derived or soybean-derived deoiled lecithin to McDougal's Buffer is applied to an ultrasonic generator to prepare a BSA emulsion. did.
上記BSA乳化液1mLを、前記バイアル瓶に分注して、前記ルーメン希釈液と混合して発酵試験液を得た。発酵試験液中の脱油レシチンの含有量は、0.1質量%又は0.3質量%となった(実施例1〜4)。 1 mL of the BSA emulsion was dispensed into the vial and mixed with the lumen dilution to obtain a fermentation test solution. The content of deoiled lecithin in the fermentation test solution was 0.1% by mass or 0.3% by mass (Examples 1 to 4).
比較のため、上記McDougall’s Bufferに、1質量%のBSAのみを添加して作製した乳化液1mLを前記バイアル瓶に分注して、前記ルーメン希釈液9mLと混合して発酵試験液を得た(比較例1)。 For comparison, 1 mL of an emulsion prepared by adding only 1% by mass of BSA to the above McDoughall's Buffer is dispensed into the vial and mixed with 9 mL of the lumen dilution to obtain a fermentation test solution. (Comparative Example 1).
さらに、上記McDougall’s Bufferに、1質量%のBSA及び3質量%の菜種油(製品名:さらさらキャノーラ油、株式会社J−オイルミルズ製)、又は大豆油(製品名:J大豆白絞油NS、株式会社J−オイルミルズ製)を添加して作製した乳化液1mLを前記バイアル瓶に分注して、前記ルーメン希釈液9mLと混合して発酵試験液を得た。発酵試験液中の菜種油又は大豆油の含有量は、0.3質量%となった(比較例2〜3)。 Further, the above McDougal's Buffer is mixed with 1% by mass of BSA and 3% by mass of rapeseed oil (product name: Sarasara Canola Oil, manufactured by J-Oil Mills Co., Ltd.) 1 ml of an emulsion prepared by adding J-Oil Mills, Inc.) was dispensed into the vial and mixed with 9 ml of the lumen dilution to obtain a fermentation test solution. The content of rapeseed oil or soybean oil in the fermentation test solution was 0.3% by mass (Comparative Examples 2-3).
上記発酵試験液を用いた発酵試験の発酵基質として、繊維質からなる炭水化物としてセルロース(濾紙)を採用した。具体的には、上記ルーメン希釈液及び上記BSA乳化液の入ったバイアル瓶内に、100mgの濾紙(製品名:ワットマンNo.1、GEヘルスケア・ジャパン株式会社製)を、投入した。その後、バイアル瓶中の気相を窒素ガスで置換し、ブチルゴム栓とアルミシールで密栓した。得られた混合液を、37℃で24時間、振とう培養した。1実験区につき、発酵実験を2反復で行った。 Cellulose (filter paper) was employed as a carbohydrate made of fiber as a fermentation substrate for the fermentation test using the fermentation test solution. Specifically, 100 mg of filter paper (product name: Whatman No. 1, manufactured by GE Healthcare Japan Co., Ltd.) was put into a vial bottle containing the above-mentioned lumen diluent and the above BSA emulsion. Thereafter, the gas phase in the vial was replaced with nitrogen gas and sealed with a butyl rubber stopper and an aluminum seal. The obtained mixed solution was cultured with shaking at 37 ° C. for 24 hours. Fermentation experiments were performed twice per experimental group.
上記培養後の発酵試験液のVFA(酢酸、プロピオン酸、酪酸、イソ酪酸、吉草酸、及びイソ吉草酸)の濃度を以下の手順で測定した。ルーメン液0.5mLに対しヘキサン0.5mLを添加した。これを懸濁させた後、遠心分離(4℃、10,000rpm,5min)により、水層とヘキサン層に分けた。水層をVFA分析用サンプルとして回収した。回収したサンプルを、以下の条件のガスクロマトグラフィー(GC)にかけた。
〔GC条件〕
Injection temp.:250℃
Column:Nukol(Supelco Inc.),30m×0.25mm×0.25μm
Initial temp.:100℃
Program rate:15℃/min
Final temp.:185℃
Detector:FID(250℃)
Carrier flow rate:1.0mL/min
Carrier gas:He
The concentration of VFA (acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, and isovaleric acid) in the fermentation test solution after the culture was measured by the following procedure. 0.5 mL of hexane was added to 0.5 mL of the rumen solution. This was suspended, and then separated into an aqueous layer and a hexane layer by centrifugation (4 ° C., 10,000 rpm, 5 min). The aqueous layer was collected as a sample for VFA analysis. The collected sample was subjected to gas chromatography (GC) under the following conditions.
[GC condition]
Injection temp. : 250 ° C
Column: Nukol (Supelco Inc.), 30 m × 0.25 mm × 0.25 μm
Initial temp. : 100 ° C
Program rate: 15 ° C / min
Final temp. 185 ° C
Detector: FID (250 ° C)
Carrier flow rate: 1.0 mL / min
Carrier gas: He
上記培養後の発酵試験液の乳酸濃度は、F−キット乳酸(J.K.インターナショナル)を用いて測定した。結果を表3及び4に示す。
表3及び4に示したとおり、発酵基質をセルロースとするin vitro発酵試験において、ルーメン液に脱油レシチンを添加した実施例1〜4では、総VFA量が、それを含まないルーメン液を用いた比較例1よりも、6〜14%増大した。また、脱油レシチンに代えて菜種油又は大豆油を用いた比較例2〜3では、VFAの減少によりルーメン発酵が抑制された。何れの試験区も、乳酸量に変化は見られなかった。これらのことから、脱油レシチンには、ルーメン液内の繊維質の発酵を促進する効果があることがわかった。 As shown in Tables 3 and 4, in Examples 1 to 4 in which deoiled lecithin was added to the rumen solution in an in vitro fermentation test using cellulose as the fermentation substrate, the total VFA amount used was a rumen solution that did not contain it. It was 6 to 14% higher than the comparative example 1. Moreover, in Comparative Examples 2-3 using rapeseed oil or soybean oil instead of deoiled lecithin, rumen fermentation was suppressed by the decrease in VFA. In any test group, no change was observed in the amount of lactic acid. From these facts, it was found that deoiled lecithin has the effect of promoting the fermentation of the fiber in the rumen fluid.
〔実施例5〜7、比較例4〕脱油レシチンのin vivo試験(1)
脱油レシチンを含む飼料を動物へ給餌したときの短鎖脂肪酸の産生に及ぼす影響を調べるため、in vivoのウシルーメン液を用いた発酵試験を実施した。
[Examples 5 to 7, Comparative Example 4] In vivo test of deoiled lecithin (1)
In order to examine the effect of the feed containing deoiled lecithin on the production of short-chain fatty acids when fed to animals, an in vivo fermentation test using bovine rumen fluid was performed.
ルーメンフィステルを装着したF1ウシ(メス)3頭(平均月齢40ヶ月)を投与試験に用いた。このウシを、コンクリート敷の牛房へ個体ごとに収容した。試験3週間前及び試験中は、ウシに抗菌剤、その他薬剤を投与しなかった。 Three F1 cows (female) equipped with lumen fistula (average age 40 months) were used in the administration test. The cows were housed individually in a concrete bed. Antibiotics and other drugs were not administered to the cows 3 weeks before and during the study.
(飼料Bの作製)
上記飼料Aに、実施例3に記載の脱油大豆レシチンを、リン脂質質量基準で0.294質量%になるように添加することにより、飼料Bを得た。
(Production of feed B)
Feed B was obtained by adding the deoiled soybean lecithin described in Example 3 to the feed A so as to be 0.294% by mass on the basis of the phospholipid mass.
(飼料Cの作製)
上記飼料Aに、実施例3に記載の脱油大豆レシチンを、リン脂質質量基準で0.589質量%になるように添加することにより、飼料Cを得た。
(Production of feed C)
Feed C was obtained by adding the deoiled soybean lecithin described in Example 3 to the feed A so as to be 0.589% by mass on the basis of phospholipid mass.
(飼料Dの作製)
上記飼料Aに、実施例3に記載の脱油大豆レシチンを、リン脂質質量基準で0.883質量%になるように添加することにより、飼料Dを得た。
(Production of feed D)
Feed D was obtained by adding the deoiled soybean lecithin described in Example 3 to the feed A so as to be 0.883% by mass based on the phospholipid mass.
1回当たり4kgの飼料A〜Dを、1日2回、5日間給与した。飼料B〜Dを投与したウシは、大豆由来の脱油レシチンをそれぞれ、36g/日(リン脂質投与量23.5g/日)、72g/日(リン脂質投与量47.1g/日)、及び108g/日(リン脂質投与量70.6g/日)摂取したことになる。 4 kg of feeds A to D were fed twice a day for 5 days. Cattle that received feeds B to D were deoiled lecithin derived from soybean, respectively, 36 g / day (phospholipid dosage 23.5 g / day), 72 g / day (phospholipid dosage 47.1 g / day), and This means that 108 g / day (phospholipid dosage 70.6 g / day) was ingested.
給与試験開始後の毎翌朝の給餌前に、ルーメンフィステルからルーメン液を約50mL採取した(計4日間)。このルーメン液を4重ガーゼでろ過し、5N−塩酸を用いてpH2に調整することで反応を停止させ、以下の分析まで冷蔵保管した。この液のVFA(酢酸、プロピオン酸、酪酸、イソ酪酸、吉草酸、及びイソ吉草酸)の濃度を、ガスクロマトグラフィーにて測定した。測定値は、4日間のサンプルの平均値±標準偏差で示した。結果を表5に示す。 About 50 mL of rumen fluid was collected from rumen fistula (four days in total) before feeding each morning after the start of the feeding test. The rumen solution was filtered with quadruple gauze, and the reaction was stopped by adjusting to pH 2 using 5N hydrochloric acid, and the refrigerator was stored refrigerated until the following analysis. The concentration of VFA (acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, and isovaleric acid) in this solution was measured by gas chromatography. The measured value was shown as the average value ± standard deviation of the samples for 4 days. The results are shown in Table 5.
表5に示したとおり、脱油大豆レシチンを含む飼料を投与した実施例7〜9では、総VFA量がそれを飼料A(比較例4)に比べて15〜19%増大した。しかも、総VFA量は、脱油大豆レシチンの投与量の濃度依存的に増加した。特に、酢酸及びプロピオン酸の増加が顕著であった。 As shown in Table 5, in Examples 7 to 9 in which the feed containing deoiled soybean lecithin was administered, the total VFA amount increased by 15 to 19% compared to Feed A (Comparative Example 4). Moreover, the total VFA amount increased depending on the concentration of the deoiled soybean lecithin dose. In particular, increases in acetic acid and propionic acid were significant.
〔実施例8及び9、比較例5及び6〕脱油レシチンのin vivo試験(2)
ルーメンフィステルを装着したF1ウシ(メス)2頭(平均月齢33ヶ月)を投与試験に用いた。このウシを、コンクリート敷の牛房へ個体ごとに収容した。試験3週間前及び試験中は、ウシに抗菌剤、その他薬剤を投与しなかった。
[Examples 8 and 9, Comparative Examples 5 and 6] In vivo test of deoiled lecithin (2)
Two F1 cows (female) equipped with lumen fistula (average age of 33 months) were used in the administration test. The cows were housed individually in a concrete bed. Antibiotics and other drugs were not administered to the cows 3 weeks before and during the study.
(飼料Eの作製)
上記飼料Aに、実施例1に記載の脱油菜種レシチンをリン脂質質量基準で0.271質量%添加することにより、飼料Eを得た。
(Production of feed E)
Feed E was obtained by adding 0.271% by mass of the deoiled rapeseed lecithin described in Example 1 to the above feed A on a phospholipid mass basis.
(飼料Fの作製)
上記粗飼料と上記濃厚飼料とを粗濃比1:4にて混合することにより、飼料Fを得た。
(Production of feed F)
The feed F was obtained by mixing the roughage and the concentrated feed in a ratio of 1: 4.
(飼料Gの作製)
上記飼料Fに、実施例1に記載の脱油菜種レシチンを、リン脂質質量基準で0.433質量%添加することにより、飼料Gを得た。
(Production of feed G)
Feed G was obtained by adding 0.433% by mass of the deoiled rapeseed lecithin described in Example 1 to the above feed F on a phospholipid mass basis.
飼料A、又は飼料E〜Gを、1回当たり2kgの濃厚飼料を含む飼料量にて、1日2回、3日間給与した。飼料E又はGを与えたウシの脱油菜種レシチン摂取量は、36g/日(リン脂質投与量21.7g/日)となった。 Feed A or feeds E to G were fed twice a day for 3 days at a feed amount containing 2 kg of concentrated feed per time. The intake of deoiled rapeseed lecithin for cattle fed with feed E or G was 36 g / day (phospholipid dosage 21.7 g / day).
給与試験後の翌朝の給餌前に、ルーメンフィステルからルーメン液を約50mL採取した。このルーメン液を4重ガーゼでろ過し、5N−塩酸を用いてpH2に調整することで反応を停止させ、以下の分析まで冷蔵保管した。この液のVFA(酢酸、プロピオン酸、酪酸、イソ酪酸、吉草酸、及びイソ吉草酸)の濃度を、ガスクロマトグラフィーにて測定した。結果を表6に示す。 About 50 mL of rumen fluid was collected from rumen fistula before feeding the next morning after the feeding test. The rumen solution was filtered with quadruple gauze, and the reaction was stopped by adjusting the pH to 2 using 5N hydrochloric acid, and stored refrigerated until the following analysis. The concentration of VFA (acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, and isovaleric acid) in this solution was measured by gas chromatography. The results are shown in Table 6.
表6から以下のことがわかる。脱油菜種レシチンを含む飼料を投与した実施例8では、総VFA量が脱油菜種レシチンを含まない飼料を投与した比較例5よりも35%増大した。飼料の粗濃比を変えた実施例9でも、同様に、総VFA量が脱油菜種レシチンを含まない飼料を投与した比較例6よりも29%増大した。特に、酢酸、プロピオン酸及び酪酸の増加が顕著であった。 Table 6 shows the following. In Example 8 in which the feed containing deoiled rapeseed lecithin was administered, the total VFA amount was increased by 35% compared to Comparative Example 5 in which the feed containing no deoiled rapeseed lecithin was administered. Similarly, in Example 9 in which the ratio of feed concentration was changed, the total VFA amount was similarly increased by 29% compared to Comparative Example 6 in which the feed containing no deoiled rapeseed lecithin was administered. In particular, increases in acetic acid, propionic acid and butyric acid were significant.
表5及び6から、脱油レシチンは、油糧種子の由来に依存せず、短鎖脂肪酸の産生を促進する効果を有することが判明した。 From Tables 5 and 6, it was found that deoiled lecithin has an effect of promoting the production of short chain fatty acids without depending on the origin of oil seeds.
粗濃比が1:1(粗飼料50質量%)の実施例8と粗濃比が1:4(粗飼料20%)の実施例9とを比べると、粗飼料の比率の高い実施例8の方が、VFA量の増大が大きかった。本発明の脱油レシチンは、粗飼料を有効に発酵させることでVFA(特に酢酸)の産生を促している。したがって、脱油レシチンを含む本発明の飼料原料は、粗飼料の割合が高い飼料に添加することが好ましいといえる。 Comparing Example 8 with a crude concentration ratio of 1: 1 (50% by weight of roughage) and Example 9 with a coarse concentration ratio of 1: 4 (20% of roughage), Example 8 with a higher ratio of roughage is better. The increase in the amount of VFA was large. The deoiled lecithin of the present invention promotes the production of VFA (particularly acetic acid) by effectively fermenting the roughage. Therefore, it can be said that it is preferable to add the feed raw material of the present invention containing deoiled lecithin to a feed having a high proportion of roughage.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015076670A JP6617245B2 (en) | 2015-04-03 | 2015-04-03 | Animal feed ingredients and their uses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015076670A JP6617245B2 (en) | 2015-04-03 | 2015-04-03 | Animal feed ingredients and their uses |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016195558A JP2016195558A (en) | 2016-11-24 |
JP6617245B2 true JP6617245B2 (en) | 2019-12-11 |
Family
ID=57357212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015076670A Active JP6617245B2 (en) | 2015-04-03 | 2015-04-03 | Animal feed ingredients and their uses |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6617245B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102072645B1 (en) * | 2017-03-10 | 2020-02-03 | 최종철 | Feed additives for a pet |
CN111449178B (en) * | 2020-05-19 | 2023-10-13 | 荆州市和美华生物科技有限公司 | Feed additive suitable for meat ducks and preparation and use methods thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0683633B2 (en) * | 1987-04-08 | 1994-10-26 | 花王株式会社 | Release oil composition for food |
JPH0975011A (en) * | 1995-09-19 | 1997-03-25 | Nippon Oil & Fats Co Ltd | Feed composition and its feeding |
JPH1084880A (en) * | 1996-09-13 | 1998-04-07 | Takeda Shokuhin Kogyo Kk | Phospholipid-containing composition having effect to promote metabolism of lipid |
JP2003284515A (en) * | 2002-03-29 | 2003-10-07 | Nisshin Oillio Ltd | Emulsifying composition for boiling rice |
BR112012029040A2 (en) * | 2010-05-14 | 2016-08-02 | Archer Daniels Midland Co | edible heat-reversible structured phospholipid organogel composition for use in a food product, method of structuring an edible organic phase, food product or ingredient, composition, method of loading an edible heat-reversible structured phospholipid organogel, method of coating a food and edible heat-resistant structured phospholipid for use in a food product |
-
2015
- 2015-04-03 JP JP2015076670A patent/JP6617245B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2016195558A (en) | 2016-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Khan et al. | Invited review: Transitioning from milk to solid feed in dairy heifers | |
Schroeder et al. | Effects of fat supplementation on milk production and composition by dairy cows on pasture: a review | |
Ayad et al. | Impact of feeding yeast culture on milk yield, milk components, and blood components in Algerian dairy herds. | |
WO2016028286A1 (en) | Coated feed composition for lactating ruminants and methods for making and using the feed composition | |
Ardalan et al. | The effect of rumen-protected methionine and choline on plasma metabolites of Holstein dairy cows | |
WO2015116232A1 (en) | Dietary compositions for ruminants and methods of making the same | |
JP6660299B2 (en) | Feed raw materials and their uses | |
US20160255864A1 (en) | Carbohydrate-containing dietary compositions and methods for their preparation and use | |
Marques et al. | Increasing dietary levels of docosahexaenoic acid-rich microalgae: Ruminal fermentation, animal performance, and milk fatty acid profile of mid-lactating dairy cows | |
Doreau et al. | Linseed plus nitrate in the diet for fattening bulls: effects on methane emission, animal health and residues in offal | |
JP2016525371A (en) | Ruminant mineral licking composition and method of making and using the same | |
US20240207335A1 (en) | Liquid feed formulation for ruminant animals and method for preparing said liquid feed formulation | |
JP6617245B2 (en) | Animal feed ingredients and their uses | |
WO2010113886A1 (en) | Agent for promoting weight gain in livestock, feed for promoting weight gain and method for promoting weight gain | |
KR20160073966A (en) | Protein-containing dietary compositions and methods for their preparation and use | |
JP6623401B2 (en) | Feed raw materials and their uses | |
Drackley | Overview of fat digestion and metabolism in dairy cows | |
CN1822772A (en) | Increasing the concentration of conjugated linoleic acid isomers in the milk fat and/or tissue fat of ruminants | |
KR102548441B1 (en) | Breeding method of korean native cattle using feed additive enhanced omega-3 fatty acid | |
WO2017002594A1 (en) | Rapeseed hull and use thereof | |
Shibata et al. | Effect of supplementation of soy sauce oil and Ca salts of fatty acids on rumen fermentation, milk production and conjugated linoleic acid in milk of dairy cows | |
Karimi et al. | Dietary application of dried citrus pulp, with or without soybean oil, in lactating Holstein cow diet: Effects on feed intake, digestibility, performance, a milk fatty acid profile and total phenolics | |
Firozi et al. | Feeding formaldehyde-treated sesame meal to lactating Murciano-Granadina goats: implications on milk yield and composition, digestibility, rumen fermentation, and blood metabolites | |
JP6621804B2 (en) | Feed composition, emulsion feed composition, and feed method of feed composition | |
Razzaghi et al. | Lactation performance, milk fat output, and nutrient digestibility responses to the addition of liquid molasses or yeast culture in dairy cows fed super-conditioned corn |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180323 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20180323 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20181018 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181113 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190110 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190220 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190610 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190730 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190905 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20191004 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6617245 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |